Vimarsana
Biggest News Aggregation in the World

Page 17 - Body Pro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Body Pro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Body Pro Today - Breaking & Trending Today

高端疫苗解盲前 食藥署公布三大審查標準 療效不能差於AZ | Anue鉅亨 - Vimarsana News

高端疫苗解盲前 食藥署公布三大審查標準 療效不能差於AZ | Anue鉅亨

高端疫苗 (6547-TW) 今 (10) 日將公布新冠疫苗二期試驗數據,衛福部食藥署今日同步公布「COVID-19 疫苗療效評估標準」,共有 3 項指標,包括應檢附資料要求、安全性評估標準和療效評估標準。

Source: cnyes.com
國產疫苗EUA標準終出爐! 開打門檻「中和抗體效價不劣於AZ疫苗」 - Vimarsana News

國產疫苗EUA標準終出爐! 開打門檻「中和抗體效價不劣於AZ疫苗」

▲國產疫苗能不能闖關成功,食藥署決定用中和抗體效價必須證明不劣於AZ疫苗為標準。匯流新聞網記者陳鈞凱

Source: yam.com
國產疫苗跟病毒搶時間 陳建仁:多國都還在三期就緊急授權 | 政治 | 三立新聞網 SETN.COM - Vimarsana News

國產疫苗跟病毒搶時間 陳建仁:多國都還在三期就緊急授權 | 政治 | 三立新聞網 SETN.COM

從國外購買的疫苗6月陸續到位,國產疫苗7月可望取得緊急授權,但外界卻質疑,為何國產疫苗只結束二期臨床,就可遞件申請緊急授權(EUA)。對此,前副總統、中研院院士、公衛權威陳建仁親上火線,以5分鐘的影片說明疫苗的三大要素「安全、有效、時效」,並指出「目前上市的COVID-19疫苗,都是在二期臨床試驗通過,還在進行三期臨床試驗的時候,就得到緊急使用授權,這是為了爭取時效的緊急保護民眾健康措施。」

Source: setn.com
《科學大家》| 新冠疫苗接種已不是選擇題,而是必答題 - Vimarsana News

《科學大家》| 新冠疫苗接種已不是選擇題,而是必答題

  出品:新浪科技《科學大家》   作者:楊曉明(國藥集團中國生物董事長、國家“863”計劃疫苗項...

Withings Health Solutions Launches Cellular Devices To Eliminate Telehealth Pain Points For Healthcare Professionals And Patients - Vimarsana News

Withings Health Solutions Launches Cellular Devices To Eliminate Telehealth Pain Points For Healthcare Professionals And Patients

Withings Health Solutions Launches Cellular Devices To Eliminate Telehealth Pain Points For Healthcare Professionals And Patients Health leader makes remote monitoring accessible and simple with cellular-connected smart scales and blood pressure monitors that require no setup and seamlessly transmit data to professionals News provided by Share this article BOSTON, Feb. 25, 2021 /PRNewswire/ -- Today, Withings, an early pioneer of the connected health revolution, takes another step to bridge the gap between patients and health professionals, unveiling a new business-to-business range of cellu...